Overall, glucose-lowering therapy was not significantly associated with a reduction in all-cause dementia or cognitive impairment. Treatment with glucagon-like peptide-1 receptor agonists (GLP ...

Significantly greater composite adverse outcome rates seen for long- vs short-term inhaled corticosteroid use for prevalent, inception cohorts. HealthDay News — For patients with chronic ...